Regulation of basement membrane-reactive B cells in BXSB, (NZBxNZW)F1, NZB, and MRL/lpr lupus mice

References

• Harley I. T., Kaufman K. M., Langefeld C. D., Harley J. B., Kelly J. A.. Genetic susceptibility to SLE: New insights from fine mapping and genome-wide association studies. Nat. Rev. Genetics. 2009; 10 5: 285–290.
   PubMed Web of Science ®Google Scholar
• Ramos P. S., Brown E. E., Kimberly R. P., Langefeld C. D.. Genetic factors predisposing to systemic lupus erythematosus and lupus nephritis. Semin. Nephrol.. 2010; 30 2: 164–176.
   PubMed Web of Science ®Google Scholar
• Kono D. H., Theofilopoulos A. N.. Genetics of SLE in mice. Springer Semin. Immunopathol.. 2006; 28 2: 83–96.
   PubMedGoogle Scholar
• Morel L.. Genetics of SLE: evidence from mouse models. Nat. Rev. Rheumatol.. 2010; 6:348–357.
   PubMed Web of Science ®Google Scholar
• Pathak S., Mohan C.. Cellular and molecular pathogenesis of systemic lupus erythematosus: lessons from animal models. Arthritis Res. Ther.. 2011; 13 5: 241.
   PubMed Web of Science ®Google Scholar
• Kyogoku C., Langefeld C. D., Ortmann W. A., . Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am. J. Hum. Genet.. 2004; 75 3: 504–507.
   PubMed Web of Science ®Google Scholar
• Kozyrev S. V., Abelson A. K., Wojcik J., . Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. Nat. Genet.. 2008; 40 2: 211–216.
   PubMed Web of Science ®Google Scholar
• Cunninghame Graham D. S., Graham R. R., Manku H., . Polymorphism at the TNF superfamily gene TNFSF4 confers susceptibility to systemic lupus erythematosus. Nat. Genet.. 2008; 40 1: 83–89.
   Google Scholar
• Gateva V., Sandling J. K., Hom G., . A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat. Genet.. 2009; 41 11: 1228–1233.
   PubMed Web of Science ®Google Scholar
• Cunninghame Graham D. S., Morris D. L., Bhangale T. R., . Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus. PLoS Genet.. 2011; 7 10: e1002341.
   PubMed Web of Science ®Google Scholar
• Zhou X. J., Lu X. L., Nath S. K., . Gene-gene interaction of BLK, TNFSF4, TRAF1, TNFAIP3, and REL in systemic lupus erythematosus. Arthritis Rheum.. 2012; 64 1: 222–231.
   Google Scholar
• Chung S. A., Taylor K. E., Graham R. R., . Differential genetic associations for systemic lupus erythematosus based on anti-dsDNA autoantibody production. PLoS Genet.. 2011; 7 3: e1001323 Epub 2011/03/17.
   PubMed Web of Science ®Google Scholar
• Hall S. W., Cooke A.. Autoimmunity and inflammation: murine models and translational studies. Mammal. Genome J. Inter. Mammal. Genome Soc.. 2011; 22 7–8: 377–389 Epub 2011/06/19. doi: 10.1007/s00335-011-9338-2.
   Google Scholar
• Sabbaga J., Line S. R. P., Potocnjak P., Madaio M. P.. A murine nephritogenic monoclonal anti-DNA autoantibody binds directly to mouse laminin, the major non-collagenous protein component of the glomerular basement membrane. Eur. J. Immunol.. 1989; 19:137–143.
   PubMed Web of Science ®Google Scholar
• Foster M. H., Sabbaga J., Line S. R. P., . Molecular analysis of nephrotropic anti-laminin antibodies from an MRL/lpr autoimmune mouse. J. Immunol.. 1993; 151:814–824.
   PubMedGoogle Scholar
• Ben-Yehuda A., Rasooly L., Bar-Tana R., . The urine of SLE patients contains antibodies that bind to the laminin component of the extracellular matrix. J. Autoimmun.. 1995; 8:279–291.
   PubMed Web of Science ®Google Scholar
• Amital H., Heilweil M., Ulmansky R., . Treatment with a laminin-derived peptide suppresses lupus nephritis. J. Immunol.. 2005; 175 8: 5516–5523.
   Google Scholar
• Amital H., Heilweil-Harel M., Ulmansky R., . Antibodies against the VRT101 laminin epitope correlate with human SLE disease activity and can be removed by extracorporeal immunoadsorption. Rheumatology (Oxford). 2007; 46 9: 1433–1437.
   Google Scholar
• Li Q. Z., Xie C., Wu T., . Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays. J. Clin. Invest.. 2005; 115 12: 3428–3439.
   PubMed Web of Science ®Google Scholar
• Fitzsimons M. M., Chen H., Foster M. H.. Diverse endogenous light chains contribute to basement membrane reactivity in nonautoimmune mice transgenic for an anti-laminin Ig heavy chain. Immunogenetics. 2000; 51:20–29.
   Google Scholar
• Rudolph E. H., Congdon K. L., Sackey F. N., Fitzsimons M. M., Foster M. H.. Humoral autoimmunity to basement membrane antigens is regulated in C57BL/6 and MRL/MpJ mice transgenic for anti-laminin Ig receptors. J. Immunol.. 2002; 168:5943–5953.
   Google Scholar
• Brady G. F., Congdon K. L., Clark A. G., . Kappa editing rescues autoreactive B cells destined for deletion in mice transgenic for a dual specific anti-laminin Ig. J. Immunol.. 2004; 172 9: 5313–5321.
   Google Scholar
• Clark A. G., Mackin K. M., Foster M. H.. Tracking differential gene expression in MRL/MpJ versus C57BL/6 anergic B cells: Molecular markers of autiommunity. Biomarker Insights. 2008; 3:335–350.
   Google Scholar
• Foster M. H., Fitzsimons M. M.. Lupus-like nephrotropic autoantibodies in nonautoimmune mice harboring an anti-basement membrane/anti-DNA Ig heavy chain transgene. Mol. Immunol.. 1998; 35:83–94.
   Google Scholar
• Clark A. G., Mackin K. M., Foster M. H.. Genetic elimination of alpha3(IV) collagen fails to rescue anti-collagen B cells. Immunol. Lett.. 2011; 141 1: 134–139.
   Google Scholar
• Oi V., Morrison S. L., Herzenberg L. A., Berg P.. Immunglobulin gene expression in transformed lymphoid cells. Proc. Natl. Acad. Sci. USA. 1983; 80:825–829.
   PubMed Web of Science ®Google Scholar
• Tybulewicz V. L. J., Crawford C. E., Jackson P. K., Bronson R. T., Mulligan R. C.. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell. 1991; 65:1153–1163.
   PubMed Web of Science ®Google Scholar
• Brochet X., Lefranc M.-P., Giudicelli V.. IMGT/V-Quest: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucl. Acids Res.. 2008; 36:W503–W508 doi: 10.1093.
   PubMed Web of Science ®Google Scholar
• Foster M. H., Cooperstone B. G., Chen H.. Anti-idiotypic monoclonal Ig specific for an anti-laminin Ig heavy chain transgene variable region. Hybridoma. 1998; 17 4: 323–329.
   Google Scholar
• Amano H., Amano E., Moll T., . The Yaa mutation promoting murine lupus causes defective development of marginal zone B cells. J. Immunol.. 2003; 170 5: 2293–2301.
   Google Scholar
• Moll T., Martinez-Soria E., Santiago-Raber M.-L., . Differential activation of anti-erythrocyte and anti-DNA autoreactive B lymphocytes by the Yaa mutation. J. Immunol.. 2005; 174:702–709.
   PubMed Web of Science ®Google Scholar
• Pisitkun P., Deane J. A., Difilippantonio M. J., . Difilippantonio et al. 2006. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science. 2006; 312 5780: 1669–1672.
   PubMed Web of Science ®Google Scholar
• Subramanian S., Tus K., Li Q. Z., . A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc. Natl. Acad. Sci. USA. 2006; 103 26: 9970–9975.
   PubMed Web of Science ®Google Scholar
• Santiago-Raber M.-L., Kikuchi S., Borel P., . Evidence for genes in addition to Tlr7 in the Yaa translocation linked with acceleration of systemic lupus erythematosus. J. Immunol.. 2008; 181:1556–1562.
   PubMed Web of Science ®Google Scholar
• Meffre E.. The establishment of early B cell tolerance in humans: lessons from primary immunodeficiency diseases. Ann. NY Acad. Sci.. 2011; 1246 1: 1–10.
   Google Scholar
• Isnardi I., Ng Y. S., Srdanovic I., . IRAK-4- and MyD88-dependent pathways are essential for the removal of developing autoreactive B cells in humans. Immunity. 2008; 29 5: 746–757.
   PubMed Web of Science ®Google Scholar
• Meyers G., Ng Y. S., Bannock J. M., . Activation-induced cytidine deaminase (AID) is required for B-cell tolerance in humans. Proc. Natl. Acad. Sci. USA. 2011; 108 28: 11554–11559.
   PubMed Web of Science ®Google Scholar
• Kuraoka M., Holl T. M., Liao D., . Activation-induced cytidine deaminase mediates central tolerance in B cells. Proceedings of the Natl. Acad. USA. 2011; 108 28: 11560–11565.
   PubMed Web of Science ®Google Scholar
• Menard L., Saadoun D., Isnardi I., . The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans. J. Clin. Invest.. 2011; 121 9: 3635–3644.
   PubMed Web of Science ®Google Scholar
• Murakami M., Tsubata T., Okamoto M., . Antigen-induced apoptotic death of Ly-1 B cells responsible for autoimmune disease in transgenic mice. Nature. 1992; 357:77–80.
   PubMed Web of Science ®Google Scholar
• Nisitani S., Sakiyama T., Honjo T.. Involvement of IL-10 in induction of autoimmune hemolytic anemia in anti-erythrocyte Ig transgenic mice. Int. Immunol.. 1998; 10 8: 1039–1047.
   Google Scholar
• Goodnow C. C., Crosbie J., Adelstein S., . Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature. 1988; 334:676–682.
   PubMed Web of Science ®Google Scholar
• Chang N.-H., Cheung Y.-H., Loh C., . B Cell activating factor (BAFF) and T cells cooperate to breach B cell tolerance in lupus-prone New Zealand Black (NZB) mice. PLoS One. 2010; 5 7: e11691.
   Google Scholar
• Santiago-Raber M. L., Amano H., Amano E., . Evidence that Yaa-induced loss of marginal zone B cells is a result of dendritic cell-mediated enhanced activation. J. Autoimmun.. 2010; 34 4: 349–355.
   Google Scholar
• Bendelac A., Bonneville M., Kearney J. F.. Autoreactivity by design: innate B and T lymphocytes. Nat. Rev. Immunol.. 2001; 1 3: 177–186.
   PubMed Web of Science ®Google Scholar
• Meyer-Bahlburg A., Rawlings D. J.. Differential impact of Toll-like receptor signaling on distinct B cell subpopulations. Front. Biosci.. 2012; 17:1499–1516.
   Google Scholar
• Grimaldi C. M., Michael D. J., Diamond B.. Cutting edge: expansion and activation of a population of autoreactive marginal zone B cells in a model of estrogen-induced lupus. J. Immunol.. 2001; 167 4: 1886–1890.
   Google Scholar
• Mackay F., Woodcock S. A., Lawton P., . Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J. Exp. Med.. 1999; 190 11: 1697–1710.
   PubMed Web of Science ®Google Scholar
• Liu Y., Li L., Kumar K. R., . Lupus susceptibility genes may breach tolerance to DNA by impairing receptor editing of nuclear antigen-reactive B cells. J. Immunol.. 2007; 179 2: 1340–1352.
   Google Scholar
• Duan B., Croker B. P., Morel L.. Lupus resistance is associated with marginal zone abnormalities in an NZM murine model. Lab. Invest. J. Tech. Meth. Pathol.. 2007; 87 1: 14–28.
   Google Scholar
• Duan B., Niu H., Xu Z., . Intrafollicular location of marginal zone/CD1d(hi) B cells is associated with autoimmune pathology in a mouse model of lupus. Lab. Invest.. 2008; 88 9: 1008–1020.
   Google Scholar
• Shao W. H., Kuan A. P., Wang C., . Disrupted Mer receptor tyrosine kinase expression leads to enhanced MZ B-cell responses. J. Autoimmun.. 2010; 35 4: 368–374.
   Google Scholar
• Zhou Z., Niu H., Zheng Y. Y., Morel L.. Autoreactive marginal zone B cells enter the follicles and interact with CD4+T cells in lupus-prone mice. BMC Immunol.. 2011; 12:7.
   PubMed Web of Science ®Google Scholar
• Wither J. E., Loh C., Lajoie G., . Colocalization of expansion of the splenic marginal zone population with abnormal B cell activation and autoantibody production in B6 mice with an introgressed New Zealand Black chromosome 13 interval. J. Immunol.. 2005; 175 7: 4309–4319.
   Google Scholar
• Foster M. H., Zhang Y., Clark A. G.. Deconstructing B cell tolerance to basement membranes. Arch. Immunol. Ther. Exp.. 2006; 54:227–237.
   Google Scholar
• Al-Qahtani A., Xu Z., Zan H., Walsh C. M., Casali P.. A role for DRAK2 in the germinal center reaction and the antibody response. Autoimmunity. 2008; 41 5: 341–352.
   PubMed Web of Science ®Google Scholar
• Wellmann U., Letz M., Schneider A., Amann K., Winkler T. H.. An Ig mu-heavy chain transgene inhibits systemic lupus erythematosus immunopathology in autoimmune (NZB × NZW)F1 mice. Int. Immunol.. 2001; 13 12: 1461–1469.
   Google Scholar
• Jacob N., Stohl W.. Autoantibody-dependent and autoantibody-independent roles for B cells in systemic lupus erythematosus: past, present, and future. Autoimmunity. 2010; 43 1: 84–97.
   PubMed Web of Science ®Google Scholar
• Roark J. H., Kuntz C. L., Nguyen K., Caton A. J., Erikson J.. Breakdown of B cell tolerance in a mouse model of systemic lupus erythematosus. J. Exp. Med.. 1995; 181:1157–1167.
   PubMed Web of Science ®Google Scholar
• Rubio C. F., Kench J., Russell D. M., Yawger R., Nemazee D.. Analysis of central B cell tolerance in autoimmune-prone MRL/lpr mice bearing autoantibody transgenes. J. Immunol.. 1996; 157:65–71.
   PubMedGoogle Scholar
• Santulli-Marotto S., Qian Y., Ferguson S., Clarke S. H.. Anti-Sm B cell differentiation in Ig transgenic MRL/Mp-lpr/lpr mice: Altered differentiation and an accelerated response. J. Immunol.. 2001; 166 8: 5292–5299.
   Google Scholar
• Chen C., Li H., Tian Q., . Selection of anti-double-stranded DNA B cells in autoimmune MRL-lpr/lpr mice. J. Immunol.. 2006; 176 9: 5183–5190 PubMed PMID: 16621982.
   Google Scholar
• Friedmann D., Yachimovich N., Mostoslavsky G., . Production of high affinity autoantibodies in autoimmune New Zealand Black/New Zealand white F1 mice targeted with an anti-DNA heavy chain. J. Immunol.. 1999; 162:4406–4416.
   PubMedGoogle Scholar
• Wellmann U., Werner A., Winkler T. H.. Altered selection processes of B lymphocytes in autoimmune NZB/W mice, despite intact central tolerance against DNA. Eur. J. Immunol.. 2001; 31:2800–2810.
   Google Scholar
• Spatz L., Saenko V., Iliev A., . Light chain usage in anti-double-stranded DNA B cell subsets: Role in cell fate determination. J. Exp. Med.. 1997; 185:1317–1326.
   PubMedGoogle Scholar
• Steeves M. A., Marion T. N.. Tolerance to DNA in (NZB x NZW)F1 mice that inherit an anti-DNA V(H) as a conventional micro H chain transgene but not as a V(H) knock-in transgene. J. Immunol.. 2004; 172 11: 6568–6577.
   Google Scholar
• Duong B. H., Ota T., Ait-Azzouzene D., . Peripheral B cell tolerance and function in transgenic mice expressing an IgD superantigen. J. Immunol.. 2010; 184 8: 4143–4158.
   PubMedGoogle Scholar
• Roes J., Rajewsky K.. Immunoglobulin D (IgD)-deficient mice reveal an auxiliary receptor function for IgD in antigen-mediated recruitment of B cells. J. Exper. Med.. 1993; 177 1: 45–55.
   PubMed Web of Science ®Google Scholar
• Nitschke L., Kosco M. H., Kohler G., Lamers M. C.. Immunoglobulin D-deficient mice can mount normal immune responses to thymus-independent and -dependent antigens. Proc. Natl. Acad. Sci. USA. 1993; 90 5: 1887–1891.
   PubMed Web of Science ®Google Scholar
• Woodward E. J., Thomas J. W.. Multiple germline kappa light chains generate anti-insulin B cells in nonobese diabetic mice. J. Immunol.. 2005; 175 2: 1073–1079.
   Google Scholar
• Henry R. A., Kendall P. L., Woodward E. J., Hulbert C., Thomas J. W.. Vkappa polymorphisms in NOD mice are spread throughout the entire immunoglobulin kappa locus and are shared by other autoimmune strains. Immunogenetics. 2010; 62 8: 507–520.
   Google Scholar
• Trepicchio W.Jr., Barrett K. J.. The Igh-V locus of MRL mice: Restriction fragment length polymorphism in eleven strains of mice as determined with VH and D gene probes. J. Immunol.. 1985; 134:2734–2739.
   PubMed Web of Science ®Google Scholar
• Kompfner E., Oliveira P., Montalbano A., Feeney A. J.. Unusual germline DSP2 gene accounts for all apparent V-D-D-J rearrangements in newborn, but not adult, MRL mice. J. Immunol.. 2001; 167 12: 6933–6938.
   Google Scholar